EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD38 high /HLA‐DR + CD8 + T lymphocytes display pathogen‐specific expansion regardless of hemophagocytic lymphohistiocytosis

Lorenzo Lodi, Walter Maria Sarli, Silvia Ricci, Laura Pisano, Silvia Boscia, Maria Vincenza Mastrolia iD, Sara Malinconi, Eleonora Fusco, Elena Sieni, Giuseppe Indolfi, Gabriele Simonini, Luisa Galli und 1 weitere

European Journal of Immunology · 2024

DOI: 10.1002/eji.202451140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Lorenzo Lodi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, ADP-ribosyl Cyclase 1, CD8-Positive T-Lymphocytes, HLA-DR Antigens. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The characteristic expansion of T CD38 high /HLA‐DR + CD8 + lymphocytes observed in hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) proved able to distinguish HLH/MAS from sepsis and systemic juvenile idiopathic arthritis. However, the performance of this marker in differentiating HLH/MAS from other pediatric febrile conditions with similar clinical onset and yet entirely different treatments remains unexplored. CD38 high /HLA‐DR + CD8 + frequencies measured in the peripheral fresh blood of pediatric patients attended for suspicion of HLH/MAS were retrospectively recorded and clinical characteristics were retrieved. CD38 high /HLA‐DR + CD8 + frequencies in HLH/MAS patients (15 patients; median: 22.0%, IQR: 11.0–49.0%) were compared with those who presented febrile conditions other‐than‐HLH (28 patients; median: 13.0%, IQR: 3.9–28.7%; p = 0.24). HLH and non‐HLH patients were subsequently regrouped based on the presence of an identified infection (22 patients; median: 27.0%, IQR: 15.2‐72.1%) and compared with those without infections (21 patients; median: 7.6%, IQR: 3.7–24.3%; p = 0.0035). CD38 high /HLA‐DR + CD8 + percentages were significantly higher only in the infection group compared with the noninfection one, with a patent pathogen‐specific expansion in Epstein–Barr virus primoinfection and visceral leishmaniasis regardless of the presence of HLH. CD38 high /HLA‐DR + CD8 + frequencies do not appear as an HLH‐specific marker as they naturally expand in other clinical situations that are common in childhood and may mimic HLH initial presentation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticADP-ribosyl Cyclase 1CD8-Positive T-LymphocytesHLA-DR AntigensHumansMaleFemaleChild, PreschoolChildInfantRetrospective StudiesMacrophage Activation SyndromeArthritis, JuvenileAdolescentMembrane GlycoproteinsHerpesvirus 4, Human

Stichwörter der Autor:innen

CD38high/HLA‐DR+CD8+ lymphocytesHemophagocytic lymphohistiocytosisMacrophage activation syndrome

Substanzen

ADP-ribosyl Cyclase 1HLA-DR AntigensCD38 protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Health Sciences, University of Florence, Florence, Italy.
  • Immunology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Rheumatology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Pediatric Hematology-Oncology Department, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Hepatology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Department NEUROFARBA, University of Florence, Florence, Italy.

ORCID-Profile: Maria Vincenza Mastrolia

Zitieren

APA

Lodi, L., Sarli, W. M., Ricci, S., Pisano, L., Boscia, S., Mastrolia, M. V., Malinconi, S., Fusco, E., Sieni, E., Indolfi, G., Simonini, G., Galli, L., & Azzari, C. (2024). CD38 high /HLA‐DR + CD8 + T lymphocytes display pathogen‐specific expansion regardless of hemophagocytic lymphohistiocytosis. European Journal of Immunology. https://doi.org/10.1002/eji.202451140

Vancouver

Lodi L, Sarli WM, Ricci S, Pisano L, Boscia S, Mastrolia MV, et al. CD38 high /HLA‐DR + CD8 + T lymphocytes display pathogen‐specific expansion regardless of hemophagocytic lymphohistiocytosis. European Journal of Immunology. 2024. doi:10.1002/eji.202451140

BibTeX
@article{Lodi2024,
  author = {Lodi, Lorenzo and Sarli, Walter Maria and Ricci, Silvia and Pisano, Laura and Boscia, Silvia and Mastrolia, Maria Vincenza and Malinconi, Sara and Fusco, Eleonora and Sieni, Elena and Indolfi, Giuseppe and Simonini, Gabriele and Galli, Luisa and Azzari, Chiara},
  title = {CD38 high /HLA‐DR + CD8 + T lymphocytes display pathogen‐specific expansion regardless of hemophagocytic lymphohistiocytosis},
  journal = {European Journal of Immunology},
  year = {2024},
  doi = {10.1002/eji.202451140}
}
Kostenlos starten →